Healthcare · Life sciences · Pharma

Consulting-grade research on a launch timeline.

HCP, payer, patient and lab-buyer evidence for every stage of a launch. Your researcher builds it around your question, and AI-moderated interviews go deep with every respondent. Launch-ready in two weeks.

Talk to our team

Client HTML Data Studio, available with any study

Research at the pace of your decisions

Fifty studies a year.
Same team.

Traditional research: 5 studies a year. With UserCue: 50 studies a year.

How it works

Human expertise, at AI scale.

One device study, and one physician traced from screen to readout. Two weeks.

  1. 01 · Kickoff

    The device team names the decision.

    Arnav: Frames the question

    Research OS structures the brief

    Kickoff call
  2. 02 · Design

    Two choice exercises, 12 tasks each.

    Arnav: Writes the guide

    Research OS programs the agents

    Choice task 3 of 12. Which would you most prefer for your early-case procedures?

    Device AHigher efficacy
    35 min total procedure time
    Higher price
    Device BLower efficacy
    35 min total procedure time
    Lower price
    Device CHigher efficacy
    65 min total procedure time
    Lower price
    One physician’s choice
  3. 03 · Fielding

    114 specialist physicians, in their own words.

    Research OS asks why

    Arnav: Reads every interview

    Live transcript · specialist physician · 14 years in practice

    “I’m booked solid, so a faster case beats a little more efficacy, honestly. And if two are equally quick, price decides it.”

    ✓ Coded · Throughput first
    Same physician, in their words
  4. 04 · Analysis

    Two camps of similar size.

    Research OS computes the model

    Arnav: Checks the story

    Share of choice importance, early cases

    Efficacy · all physicians32.4%
    Efficacy · outcome-led43.2%
    Efficacy · throughput-led13.7%
    Procedure time · all physicians14.8%
    Procedure time · outcome-led6.3%
    Procedure time · throughput-led28.6%
    All physicians n = 114 · outcome-led n = 56 · throughput-led n = 50
    Their 24 choices, in the model
  5. 05 · Readout

    The average describes neither camp.

    Arnav: Presents it live

    Research OS renders the report

    This physician, in three figures

Selected research

Research for every decision in the product lifecycle.

PharmaCombination regimen choice

150 community and academic specialists, before a pivotal trial.

What it found

51% of community specialists choose the partner drug mainly on coverage.

Other research we run

Your researcher shapes each study around where the product is in its lifecycle.

  • Market sizing and forecast
  • Patient flow analysis
  • KOL mapping
  • Competitive landscape
  • Unmet needs
  • Segmentation
  • Concept and message testing
  • TPP testing
  • Positioning and claims testing
  • Persona research
  • Usability and workflow fit
  • MaxDiff prioritization
  • Van Westendorp pricing
  • Gabor-Granger pricing
  • Choice-based conjoint
  • Willingness to pay
  • Payer and market access
  • Referral and access pathways
  • Voice of the customer
  • Brand health and ATU
  • Adoption and switching
  • Wave studies
  • Advisory boards
  • NPS key driver analysis

If your team needs it, we run it.

Talk to our team

How it compares

Primary research was missing an expert-led, AI-native option.

Launch-ready insight, without the agency timeline.

Senior researchers lead

Agencies and consultancies

Senior expertise. More manual workflow. Longer timelines.

Senior researchers lead, traditional workflow.

UserCueResearch OS

Senior expertise. AI-native workflow. Two weeks.

Senior researchers lead, AI-native workflow.

Your team leads

Expert networks and panel providers

Respondent access. Your team leads the research and the synthesis.

Your team leads, traditional workflow.

Self-serve AI platforms

Your team leads the research, with the platform’s panel or synthetic respondents.

Your team leads, AI-native workflow.
What clients say
“The depth of clinical insight was exceptional. What would have taken our team months to piece together from multiple vendors arrived in ten days, with the rigor we needed to present to our medical advisory board.”VP, Global Insights · Top-20 pharma · Oncology commercial strategy

Ready to move at launch speed?

30 minutes. No pitch deck. We’ll walk through a sample deliverable for your therapeutic area or market and show you exactly how we’d approach your next study.